Next Article in Journal
Effect of Process Parameters on the Initial Burst Release of Protein-Loaded Alginate Nanospheres
Previous Article in Journal
Study of an Additional Layer of Cement Mantle Hip Joints for Reducing Cracks
Previous Article in Special Issue
Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
Open AccessArticle

Silk-Based Therapeutics Targeting Pseudomonas aeruginosa

Department of Biomedical Engineering, Tufts University, 4 Colby St, Medford, MA 02155, USA
*
Author to whom correspondence should be addressed.
J. Funct. Biomater. 2019, 10(3), 41; https://doi.org/10.3390/jfb10030041
Received: 6 August 2019 / Revised: 10 September 2019 / Accepted: 11 September 2019 / Published: 13 September 2019
(This article belongs to the Special Issue Functional Biomaterials in Drug Delivery Applications)
Pseudomonas aeruginosa (P. aeruginosa) infections may lead to severe damage of the cornea, mucosa, and skin. The highly aggressive nature of P. aeruginosa and the rise in multi-drug resistance, particularly in nosocomial settings, lead to an increased risk for permanent tissue damage and potentially death. Thus, a growing need exists to develop alternative treatments to reduce both the occurrence of bacterial infection and biofilm development, as well as pathological progression post-infection. Silk derived from Bombyx mori silkworms serves as a unique biomaterial that is biocompatible with low immunogenicity and high versatility, and thereby ideal for stabilizing therapeutics. In this study, we assessed the cytotoxicity of P. aeruginosa on human corneal stromal stem cells and two mucosal cell lines (Caco-2 and HT29-MTX). To determine whether antibiotic-immobilized scaffolds can serve as alternative therapeutics to free, diffuse forms, we developed novel gentamicin-conjugated silk films as functional scaffolds and compared antimicrobial effects and free gentamicin. The advantages of generating a surface coating with a covalently-bound antibiotic may reduce potential side-effects associated with free gentamicin, as well as limit the diffusion of the drug. Our results suggest that gentamicin conjugated to native silk and carboxyl-enriched silk inhibits P. aeruginosa growth. Development of stabilized antibiotic treatments with surface toxicity selective against bacteria may serve as an alternative approach to treat active infections, as well as potential prophylactic use as coatings in high-risk cases, such as post-surgical complications or prolonged hospitalization. View Full-Text
Keywords: silk; Pseudomonas aeruginosa; scaffold; antibiotic silk; Pseudomonas aeruginosa; scaffold; antibiotic
Show Figures

Figure 1

MDPI and ACS Style

McKay, T.B.; Parker, R.N.; Hawker, M.J.; McGill, M.; Kaplan, D.L. Silk-Based Therapeutics Targeting Pseudomonas aeruginosa. J. Funct. Biomater. 2019, 10, 41.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop